Using in vitro studies and in vivo mouse genetic models they determined that ZFP423 modulates NF-κB activity and that expression of ZFP423 in perivascular mesenchymal cells suppresses inflammatory signaling in FIPs and attenuates metabolic inflammation in obesity [102]. The gene discussed is ZNF423; the disease is obesity disorder.